“Effects for the elderly… Reserve 500 million times for Kobax”
A prototype of the Corona 19 vaccine developed by Janssen, a European subsidiary of the US pharmaceutical company J&J, was provided in September of last year. AP Newsis
Following the European Union (EU), the World Health Organization (WHO) has also approved the use of the Johnson & Johnson (J&J) novel coronavirus infection (Corona 19) vaccine, which requires only one injection.
In a statement on the 12th (local time), the WHO said, “The Corona 19 vaccine Ad26.COV2.S developed by Janssen has been put on the urgent use list.” Janssen is a European subsidiary of J&J, an American pharmaceutical company. The WHO added, “The wealth of data from large-scale clinical trials shared by the company shows that this vaccine is also effective for older people.”
The big advantage of the J&J vaccine is that it can be effective with just one vaccination. Other vaccines previously approved require two doses. It is also easy to distribute. In principle, it is kept at -20 degrees Celsius, but it can be maintained for 3 months at 2-8 degrees Celsius. Therefore, it has been attracting attention as a’game changer’ that can dramatically increase the speed of inoculation.
It is an evaluation that there is no problem with efficacy. As a result of the final clinical trial, the preventive effect (66%) was lower than that of Pfizer (95%) or Modena (94.1%) vaccines, but experts say that only J&J should take into account the fact that the trial was conducted after the virus spread.
The trigger for this decision was the recommendation for approval by the European Medicines Agency (EMA) the day before. The WHO explained that “to expedite the listing of this vaccine, we adopted a’brief evaluation’ based on the results of the EMA’s review.” He said, “We will convene the Expert Strategy Advisory Group (SAGE), an immunization advisory group, next week to come up with recommendations on vaccine use.”
In addition, the WHO announced that it has reserved 500 million doses of J&J vaccines for’CoVax Facility’ (a global vaccine co-distribution/purchasing association). WHO Senior Advisor Bruce Aleward said in a video briefing that day, “We hope to have access to the order by at least July.”
The WHO’s approval for the use of the corona vaccine is the J&J vaccine following the Pfizer-Bioentech vaccine and the AstraZeneca-Oxford vaccine.
Kwon Gyeong-seong reporter [email protected]
Subscribe to the Hankook Ilbo News Naver Channel
Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo